The Global Investor Network for Physicians
We are hundreds of physicians working together to identify, evaluate and support emerging Medtech companies. We call our approach MD Advantage—in addition to traditional investments, we invest our clinical expertise, adding value to companies and accelerating access to clinical solutions for our patients.
Maintain your Investment Advantage as an MD/PhD
Don’t Get Sidelined
The physician community is uniquely qualified to evaluate the potential of emerging medical technologies - yet are often marginalized by large financial institutions who invest during a company's growth.
We counter this with a unique MD-friendly investment vehicle - not a fund - in which physicians retain control.
The Power of Partnership, the Freedom of Individual Choice
A Bloc of Physician Leaders
By bringing a bloc of physician leaders to the cap table, NTI is frequently able to set terms, or negotiate better terms for MDs.
Benefits for the Entire Group
NTI warrants, board seats and other terms benefit the entire group
Early Access to Seed and Series A Deals
NTI enables early physician access to a Seed and Series A portfolio that might not otherwise be available
No Requirement to Invest
Physician members have no requirement to invest
No Fees
Physican members incur no fees - Deal expenses are covered by management until an exit occurs
Invest as a Group
Investing as a group provides leverage to negotiate better terms
Have impact
Impact the direction or outcome of a company over time
Physicians Add Value to Companies
- Cash/Capital
- Validation by Key Opinion Leaders
- Deep understanding of market potential; both near- and long-term opportunities
- Strong personal relationships with major strategic neuro and vascular acquirers
- IP; innovative ideas brought to life
- Resources (CROs, testing facilities, contract manufacturing)
Early Physician Access Benefits Patients and Grows Companies
Our physician network identifies, invests, and provides operational expertise to promising medical technologies along their development lifecycle, from concept to commercialization.
EndoStream aneurysm devices utilize self-conforming scaffolds that adapt to an aneurysm’s unique shape and provide maximal neck metal coverage. NTI physicians have played a key role—in driving EndoStream forward.
Radical Catheter Technologies have developed a completely new design platform that enables catheters to navigate more smoothly and distally through tortuous anatomy, enabling more efficient complex procedures. NTI physicians have been critical to Radical’s progress.
Synchron’s Brain Computer Interface allows paralyzed patients to type with their brains. NTI physicians have been key to propelling Synchron forward—enabling the company to be the first brain-computer-interface to begin human trials.
